Author Archives: Jennifer Walker-Journey
FDA panel considers benefits, risks of experimental rheumatoid arthritis drug
Drug regulators are questioning whether an experimental drug for rheumatoid arthritis has too great of a cancer risk and whether it actually works as well as the drug company claims. The drug, tofacitinib, marketed by Pfizer, is under review by
FDA considers approval of HIV drug to prevent AIDS virus
For the first time, the Food and Drug Administration (FDA) will consider whether to allow a drug company to market a widely prescribed HIV drug for the prevention of the virus that causes AIDS.
Development of new cholesterol drug halted due to lack of efficacy
Development on a potential blockbuster cholesterol drug has been halted by the manufacturer because the medication failed to provide benefit when added to existing standard of care in patients with coronary heart disease. A pharmaceutical product is considered a “blockbuster
Common infertility treatments may increase risk of birth defects
Babies born with the help of common fertility treatments including in vitro fertilization (IVF) and the drug Clomid are at greater risk of birth defects, according to a new study published this month in the New England Journal of Medicine.
Canadian woman files bladder sling lawsuit
Jane Dowall had no idea she would end up in so much pain following surgery to fix her urinary incontinence. “The pain is like a migraine headache… from knees to naval,” she told CTV. “Sometimes it’s a burning, sometimes it
Kids with type 2 diabetes have limited treatment options
The rising number of kids being diagnosed with type 2 diabetes has created new challenges on how to manage the “adult-onset” disease in young people, according to concerns raised at a recent meeting of pediatricians in Boston.
Public Citizen petitions FDA to ban diabetes drug Victoza due to thyroid cancer risk
Public watchdog group Public Citizen is petitioning the U.S. Food and Drug Administration (FDA) to pull the type 2 diabetes drug Victoza off the market because it puts patients at higher risk for thyroid cancer, pancreatitis, serious allergic reactions, and
AF patients who stop using blood thinners are at greater risk for stroke
When people with atrial fibrillation (AF) stop taking a blood thinner, their risk of having a stroke increases dramatically, according to a new study.
FDA approves new medication for erectile dysfunction
Move over Viagra and Cialis, there’s a new erectile dysfunction drug in town, and it’s name is Stendra.
